Talphera, Inc. (TLPH)
Develops injectable drugs that prevent blood clots in medical procedures and treat serious conditions.
$1.30+0.03%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+225.0%
The outlook
TLPH is trading at $1.30, positioned well above its 50- and 200-day moving averages and sitting near the upper end of its 52-week range. Analyst sentiment is notably bullish, with an average price target implying roughly 144% upside from current levels. The stock shows strength in its near-term technicals, though actual coverage remains limited.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range77% of the way from its 52-week low to high
Price targetAvg target +144% vs current price
Analyst price target
~12-month · 3 analysts$3.17average target+143.6% vs now
Now $1.30
Low $3.00High $3.50
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$67.5M
52-wk high
$1.57
52-wk low
$0.39
50-day avg
$1.03
200-day avg
$1.02
Trailing P/E
—